Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gresele

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
European Journal of Pharmacology|June 14, 2000
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirinS Momi, M Emerson, W Paul, et al.
Diabetologia|November 21, 2007
Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patientsM Giordano, P Lucidi, T Ciarambino, et al.
Platelets|November 4, 2010
Original Article: Albumin Prevents TxB, Formation from Thrombin-stimulated Human Platelets by Sequestering the Liberated Arachidonic Acid in the Extracellular SpaceS Porcellati, P Gresele, M Stasi, et al.
Clinical Science (London, England : 1979)|October 1, 1985
Partial isolation and function of the prostacyclin regulating plasma factorH Deckmyn, C Zoja, J Arnout, et al.
Platelets|February 3, 2011
Incomplete inhibition of platelet function as assessed by the platelet function analyzer (PFA-100) identifies a subset of cardiovascular patients with high residual platelet response while on aspirinM Crescente, A M Mezzasoma, M Del Pinto, et al.
ASAIO Transactions|July 1, 1991
Liquid nitrogen snap frozen saphenous vein for vascular access in dialysisA Baraldi, D Bonucchi, A Di Felice, et al.
Lancet (London, England)|May 4, 1985
Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipientsY Vanrenterghem, L Roels, T Lerut, et al.
Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expressionM R Rossiello, S Momi, R Caracchini, et al.
Circulation|July 1, 1997
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial diseaseG Davì, P Gresele, F Violi, et al.
Gastroenterology|August 1, 1992
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregationG Laffi, F Marra, P Gresele, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
European Journal of Pharmacology|June 14, 2000
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirinS Momi, M Emerson, W Paul, et al.
Diabetologia|November 21, 2007
Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patientsM Giordano, P Lucidi, T Ciarambino, et al.
Platelets|November 4, 2010
Original Article: Albumin Prevents TxB, Formation from Thrombin-stimulated Human Platelets by Sequestering the Liberated Arachidonic Acid in the Extracellular SpaceS Porcellati, P Gresele, M Stasi, et al.
Clinical Science (London, England : 1979)|October 1, 1985
Partial isolation and function of the prostacyclin regulating plasma factorH Deckmyn, C Zoja, J Arnout, et al.
Platelets|February 3, 2011
Incomplete inhibition of platelet function as assessed by the platelet function analyzer (PFA-100) identifies a subset of cardiovascular patients with high residual platelet response while on aspirinM Crescente, A M Mezzasoma, M Del Pinto, et al.
ASAIO Transactions|July 1, 1991
Liquid nitrogen snap frozen saphenous vein for vascular access in dialysisA Baraldi, D Bonucchi, A Di Felice, et al.
Lancet (London, England)|May 4, 1985
Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipientsY Vanrenterghem, L Roels, T Lerut, et al.
Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expressionM R Rossiello, S Momi, R Caracchini, et al.
Circulation|July 1, 1997
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial diseaseG Davì, P Gresele, F Violi, et al.
Gastroenterology|August 1, 1992
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregationG Laffi, F Marra, P Gresele, et al.
Pageof 13